Literature DB >> 24267811

Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis.

Ana C Alba1, Juarez Braga, Mena Gewarges, Stephen D Walter, Gordon H Guyatt, Heather J Ross.   

Abstract

BACKGROUND: Many current predictors of mortality in heart failure (HF) were evaluated before the use of implantable cardioverter defibrillators (ICDs). We conducted a meta-analysis to identify factors associated with mortality in ICD-HF patients.
METHODS: We searched in MedLine, EMBASE, and CINAHL in May 2012. Two reviewers selected citations that included ambulatory ICD patients and addressed the association between any predictor and mortality using multivariable regression. We meta-analyzed mortality using random-effects models.
RESULTS: Of 10,420 studies reviewed, 72 studies evaluating 63 predictors on 257,692 ICD patients proved eligible. High confidence in estimates was found for age (hazard ratio [HR], 1.45 for 10-year increase; 95% confidence interval [CI], 1.35-1.56), baseline glomerular filtration rate (HR, 1.25 for 15-mL/min decrease; 95% CI, 1.15-1.35), chronic obstructive pulmonary disease (HR, 1.54; 95% CI, 1.38-1.71), diabetes (HR, 1.56; 95% CI, 1.37-1.79), peripheral vascular disease (HR, 1.43; 95% CI, 1.2-1.72), left ventricular ejection fraction (HR, 0.77 for 10% increase; 95% CI, 0.73-0.83), and appropriate or inappropriate ICD shocks (HR, 2.34; 95% CI 1.59-3.44) New York Heart Association class, atrial fibrillation, and congestive HF were strongly associated with mortality but the confidence in estimates was low. Ischemic cardiomyopathy and male sex were not independent predictors of mortality.
CONCLUSIONS: This meta-analysis identified strong reliable mortality predictors in ICD-HF patients. Age, renal dysfunction, chronic obstructive pulmonary disease, diabetes, peripheral vascular disease, decreased left ventricular ejection fraction, and ICD shocks during follow-up were strong predictors of mortality; ischemic cardiomyopathy and male sex were not. Further research is needed to study other potential predictors, particularly biomarkers.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24267811     DOI: 10.1016/j.cjca.2013.09.024

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  10 in total

1.  Nursing Home Use After Implantable Cardioverter-Defibrillator Implantation in Older Adults: Results from the National Cardiovascular Data Registry.

Authors:  Daniel B Kramer; Matthew R Reynolds; Sharon-Lise Normand; Craig S Parzynski; John A Spertus; Vincent Mor; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2016-11-07       Impact factor: 5.562

2.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

3.  Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.

Authors:  Malini Madhavan; Jonathan W Waks; Paul A Friedman; Daniel B Kramer; Alfred E Buxton; Peter A Noseworthy; Ramila A Mehta; David O Hodge; Angela Y Higgins; Tracy L Webster; Chance M Witt; Yong-Mei Cha; Bernard J Gersh
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

Review 4.  Decision-making under uncertainty in advanced heart failure.

Authors:  Theo E Meyer; Michael S Kiernan; David D McManus; Jeffrey Shih
Journal:  Curr Heart Fail Rep       Date:  2014-06

5.  Comparative effectiveness of cardiac implantable electrical devices.

Authors:  Daniel B Kramer; Laura A Hatfield; Sharon-Lise T Normand
Journal:  Heart       Date:  2015-08-24       Impact factor: 5.994

6.  Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.

Authors:  Ruben E Hernandez; Steve K Singh; Dale T Hoang; Syed W Ali; MacArthur A Elayda; Hari R Mallidi; O H Frazier; Deborah E Meyers
Journal:  Tex Heart Inst J       Date:  2015-10-01

7.  Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study.

Authors:  Daniel B Kramer; Susan L Mitchell; Joao Monteiro; Paul W Jones; Sharon-Lise Normand; David L Hayes; Matthew R Reynolds
Journal:  J Am Heart Assoc       Date:  2015-05-15       Impact factor: 5.501

8.  Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry.

Authors:  Daniel B Kramer; Matthew R Reynolds; Sharon-Lise Normand; Craig S Parzynski; John A Spertus; Vincent Mor; Susan L Mitchell
Journal:  Circulation       Date:  2016-03-25       Impact factor: 29.690

9.  Interaction between electrical storm and left ventricular ejection fraction as predictors of mortality in patients with implantable cardioverter defibrillator: A Chinese cohort study.

Authors:  Zhengqin Zhai; Shuang Zhao; Xiaoyao Li; Keping Chen; Wei Xu; Wei Hua; Yangang Su; Min Tang; Zeyi Li; Shu Zhang
Journal:  Front Cardiovasc Med       Date:  2022-07-29

10.  Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators.

Authors:  Kanako Ichikura; Sayaka Kobayashi; Shiho Matsuoka; Tsuyoshi Suzuki; Katsuji Nishimura; Tsuyoshi Shiga; Nobuhisa Hagiwara; Jun Ishigooka; Shin-Ichi Suzuki
Journal:  Int J Clin Health Psychol       Date:  2016-11-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.